Literature DB >> 30912203

JNK signaling in cancer cell survival.

Qinghua Wu1,2,3, Wenda Wu2,3, Bishi Fu4, Lei Shi5, Xu Wang6, Kamil Kuca3,7.   

Abstract

c-Jun N-terminal kinase (JNK) is involved in cancer cell apoptosis; however, emerging evidence indicates that this Janus signaling promotes cancer cell survival. JNK acts synergistically with NF-κB, JAK/STAT, and other signaling molecules to exert a survival function. JNK positively regulates autophagy to counteract apoptosis, and its effect on autophagy is related to the development of chemotherapeutic resistance. The prosurvival effect of JNK may involve an immune evasion mechanism mediated by transforming growth factor-β, toll-like receptors, interferon-γ, and autophagy, as well as compensatory JNK-dependent cell proliferation. The present review focuses on recent advances in understanding the prosurvival function of JNK and its role in tumor development and chemoresistance, including a comprehensive analysis of the molecular mechanisms underlying JNK-mediated cancer cell survival. There is a focus on the specific "Yin and Yang" functions of JNK1 and JNK2 in the regulation of cancer cell survival. We highlight recent advances in our knowledge of the roles of JNK in cancer cell survival, which may provide insight into the distinct functions of JNK in cancer and its potential for cancer therapy.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  JNK; c-Jun N-terminal kinase; cancer; cell survival; chemoresistance; tumor development

Mesh:

Substances:

Year:  2019        PMID: 30912203     DOI: 10.1002/med.21574

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  60 in total

1.  Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.

Authors:  Igor A Schepetkin; Alexander S Karpenko; Andrei I Khlebnikov; Marina O Shibinska; Igor A Levandovskiy; Liliya N Kirpotina; Nadezhda V Danilenko; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2019-09-18       Impact factor: 6.514

Review 2.  JNK signaling as a target for anticancer therapy.

Authors:  Kamal S Abdelrahman; Heba A Hassan; Salah A Abdel-Aziz; Adel A Marzouk; Atsushi Narumi; Hiroyuki Konno; Mohamed Abdel-Aziz
Journal:  Pharmacol Rep       Date:  2021-03-12       Impact factor: 3.024

Review 3.  The JAK/STAT signaling pathway: from bench to clinic.

Authors:  Xiaoyi Hu; Jing Li; Maorong Fu; Xia Zhao; Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-11-26

4.  Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.

Authors:  Tianzhen Hu; Chengyun Pan; Tianzhuo Zhang; Ming Ni; Weili Wang; Siyu Zhang; Ying Chen; Jishi Wang; Qin Fang
Journal:  Cancer Gene Ther       Date:  2022-07-15       Impact factor: 5.854

Review 5.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

6.  CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway.

Authors:  Li-Le Wang; Rui-Cheng Hu; Ai-Guo Dai; Shuang-Xiang Tan; Ming Xu; Chun-Chu Kong; Yun-Rong Chen; Dai-Yan Fu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

7.  Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non-transformed skeletal muscle cells.

Authors:  Shekoufeh Almasi; Tara E Crawford Parks; Aymeric Ravel-Chapuis; Alex MacKenzie; Jocelyn Côté; Kyle N Cowan; Bernard J Jasmin
Journal:  Cell Oncol (Dordr)       Date:  2021-04-26       Impact factor: 6.730

8.  Antitumor Effects of Carvacrol and Thymol: A Systematic Review.

Authors:  Laeza Alves Sampaio; Lícia Tairiny Santos Pina; Mairim Russo Serafini; Débora Dos Santos Tavares; Adriana Gibara Guimarães
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

Review 9.  JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation.

Authors:  Shing Yau Tam; Helen Ka-Wai Law
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

10.  KRT18 Modulates Alternative Splicing of Genes Involved in Proliferation and Apoptosis Processes in Both Gastric Cancer Cells and Clinical Samples.

Authors:  Biao Chen; Ximing Xu; Dan-Dan Lin; Xin Chen; Yang-Tao Xu; Xin Liu; Wei-Guo Dong
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.